Enamel matrix derivative promotes human periodontal ligament cell differentiation and osteoprotegerin production in vitro.
Enamel matrix derivative (EMD) has been used successfully to aid periodontal repair. We sought to elucidate the mechanism of action of EMD and hypothesized that combined exposure to EMD and parathyroid hormone (PTH), which acts anabolicly when administered intermittently, would enhance periodontal ligament cell proliferation, differentiation, and local factor production. Confluent human periodontal ligament cells were exposed to EMD continuously or to PTH(1-34) intermittently, or a combination of both. Cell number, alkaline phosphatase activity, osteocalcin, and osteoprotegerin production were determined. Continuous challenge with EMD resulted in an increase of the differentiation parameters and osteoprotegerin production, while simultaneously inhibiting proliferation. Intermittent PTH(1-34) administration exerted opposite effects. Combined administration of EMD and PTH(1-34) weakened or even nullified the effects seen for the agents alone. These results suggest that EMD promotes periodontal ligament cell differentiation and osteoprotegerin production, potentially resulting in a microenvironment supporting periodontal repair, whereas combining EMD and PTH(1-34) failed to prove beneficial in this respect.
Lossdörfer
S
S
Department of Orthodontics, Dental Clinic, University of Bonn, Welschnonnenstr. 17, 53111 Bonn, Germany.
Sun
M
M
Götz
W
W
Dard
M
M
Jäger
A
A
D000293:Adolescent; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002648:Child; D003746:Dental Enamel Proteins / Q000494:pharmacology*; D004338:Drug Combinations; D006801:Humans; D053244:Osteoprotegerin / Q000096:biosynthesis*; D010281:Parathyroid Hormone / Q000494:pharmacology; D010513:Periodontal Ligament / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D012038:Regeneration / Q000187:drug effects*; D018709:Statistics, Nonparametric
D003746:Dental Enamel Proteins; D004338:Drug Combinations; D053244:Osteoprotegerin; D010281:Parathyroid Hormone; C109069:enamel matrix proteins